NEWSEven if this drug is completely shot down by the FDA Friday, can it not be sent through to be approved in Europe? i know they run by the same guidelines as the FDA by IPN or whatever it is , but Ispen / France /
All i keep hearing is how this management team is horrible ... So im kind of thinking they arent actively seeking that route these past few months, or even having a potential US partner that could carry out 2nd Stage 3 clinicals.
hopefully they have because an FDA reversal is next to impossible and like others on this board have been saying, the FDA shot down this drug with a few nice words added, but the answer was pretty clear.
Dont get me wrong, im not a basher, im in heavily into this stock and would like nothing better than this stock to soar.
Wishful thinking that the management has a positive news release coming to get some upward movement.